NorthWest Biotherapeutics Inc (NWBO)

[beachhyena]

Maybe just maybe a contract between NWBO and Cognate/CRL is not required at this point. I say this because NWBO has gone into a self imposed quiet period and it looks like they are proving that they will have capacity to start manufacturing very shortly in the UK albeit for specials only at this point. More importantly I believe work is also being concurrently advanced with Flaskworks per recent posts by iwasadiver. The companies goals have certainly changed since they acquired Flaskworks and they must believe this is the way forward.
When DCVAX-L meets full approval here in the US sometime after topline and publication I believe they will be in a better position to assess how they meet demand, and if they do indeed need CRL will renegotiate at that point.
We also have the outlier that may still be in play and that is a partner is waiting in the wings for NWBO to reach a number of set goals before they step in, some of these goals may involve Sawston/Flaskworks/Publication/TLD etc. Flipper has outlined many of these goals and events within the oncology space that have been highlighting the growing importance that a new paradigm to treat GBM is revealed in short order. JMHO.